Our group has shown that there is crosstalk between the TGFβ2 and TLR4 signaling pathways in the TM and that this crosstalk is contributing to glaucomatous ocular hypertension (Figure 2) (Hernandez et al., 2017). The gene discussed is TLR4; the disease is ocular hypertension.